LSX World Congress USA is a premier B2B event in Boston, MA, dedicated to fostering innovation, investment, and strategic partnerships within the North American life sciences sector. It brings together a high-caliber delegation of founders, CEOs, senior executives, active investors, and leaders from major pharmaceutical and medtech companies. This congress is essential for companies seeking capital, pursuing strategic alliances, and navigating growth. Attendees benefit from unparalleled opportunities for networking, knowledge sharing, and deal-making, ultimately shaping the future of healthcare technology and patient outcomes. With focused content tracks on capital markets, pharma partnering, and market commercialization, the event provides comprehensive coverage of critical industry topics, making it a vital forum for strategic decision-making and advancing healthcare innovation.
Highlights
5 items
01
Extensive 1-2-1 Partnering
Facilitates direct connections between companies, investors, and potential partners for deal-making and collaboration.
02
High-Caliber Global Audience
Attracts founders, CEOs, investors, and leaders from top pharma and medtech companies worldwide.
03
Focused Content Tracks
Offers dedicated sessions on Capital Markets, Pharma Partnering, and Market Commercialization strategies.
04
Legacy of Life Sciences Innovation
Builds on over a decade of experience, evolving from the renowned 'Biotech and Money' event.
05
Strategic Boston Location
Positioned in a key hub for life sciences, enhancing networking and access to innovation opportunities.
FAQ
5 questions
The congress targets founders, CEOs, investors, and leaders from innovative start-ups, growth-stage, and publicly listed life science companies, as well as pharma and big medtech executives.
It covers the biotech, medtech, and healthtech industries, showcasing advancements in pharmaceuticals, medical devices, and digital health.
Key activities include extensive 1-2-1 partnering opportunities, high-level keynote panels, and discussions across dedicated content tracks focusing on investment and commercialization.
The event is organized by LSX Ltd., a specialist entity under the broader Informa Group, renowned for executive-level conferences.
The event was formerly known as "Biotech and Money" and has a history spanning over a decade.
